Transferrin-Functionalized Liposomes Enhance MAPT-ASO Transport Across a 3D Blood–Brain Barrier Microvascular Network Model
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311347 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Simon Konig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University College London, London WC1E 6BT, UK. Hauptthemen laut MEDLINE: Blood-Brain Barrier, tau Proteins, Transferrin, Liposomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Cancer Research UK, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Tau pathology is a defining hallmark of Alzheimer’s disease (AD), closely associated with cognitive decline. Antisense oligonucleotides targeting the tau-encoding gene MAPT (MAPT-ASO) have shown promise in clinical trials, but their therapeutic potential is limited by poor delivery across the blood–brain barrier (BBB). In this study, we developed transferrin (TF)-functionalized liposomes encapsulating MAPT-ASOs and evaluated their transport across a 3D self-assembled microvascular BBB model composed of human brain microvascular endothelial cells, astrocytes, and pericytes embedded in a fibrin hydrogel. Following confirmation of MAPT-ASO efficacy in reducing tau levels and protecting against glutamate-induced axonal degeneration, we observed significantly enhanced extravascular accumulation and sustained delivery of MAPT-ASOs with TF-functionalized liposomes over 24 h, compared to non-functionalized control liposomes. This study presents a novel delivery strategy for a functionally effective tau-targeting anti-sense oligonucleotide (ASO), potentially enabling systemic delivery rather than intrathecal administration. In addition, this study demonstrates the utility of the 3D in vitro BBB model for screening and optimizing brain delivery of nucleic acid-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mechanical Engineering, University College London, London WC1E 6BT, UK.
- School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.
- BioRecode Ltd., London EC4N 7BE, UK.
ORCID-Profile: Simon Konig, Xinai Shen, Giuseppe Mantovani, Gerlof Sebastiaan Winkler, Zheying Zhu, Emad Moeendarbary
Förderung
- Biotechnology and Biological Sciences Research Council
- Cancer Research UK
- Engineering and Physical Sciences Research Council
- BBSRC
- Cancer Research UK Multidisciplinary Award
- EPSRC
- School of Pharmacy, The University of Nottingham, UK
Zitieren
APA
Konig, S., Shen, X., Mantovani, G., Winkler, G. S., Zhu, Z., & Moeendarbary, E. (2025). Transferrin-Functionalized Liposomes Enhance MAPT-ASO Transport Across a 3D Blood–Brain Barrier Microvascular Network Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311347
Vancouver
Konig S, Shen X, Mantovani G, Winkler GS, Zhu Z, Moeendarbary E. Transferrin-Functionalized Liposomes Enhance MAPT-ASO Transport Across a 3D Blood–Brain Barrier Microvascular Network Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311347
BibTeX
@article{Konig2025,
author = {Konig, Simon and Shen, Xinai and Mantovani, Giuseppe and Winkler, Gerlof Sebastiaan and Zhu, Zheying and Moeendarbary, Emad},
title = {Transferrin-Functionalized Liposomes Enhance MAPT-ASO Transport Across a 3D Blood–Brain Barrier Microvascular Network Model},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311347}
}
EUVIMED